• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue.

作者信息

Martin W, Spyt T, Thomas I, Davidson J F, Wheatley D J

机构信息

Department of Cardiac Surgery, Royal Infirmary, Glasgow, Scotland.

出版信息

Eur J Nucl Med. 1989;15(3):128-32. doi: 10.1007/BF00254624.

DOI:10.1007/BF00254624
PMID:2469579
Abstract

The degree of extracorporeal platelet sequestration in 32 patients undergoing cardiopulmonary bypass has been assessed using 111In labelled platelets and both a shadow shield whole body monitor and a standard gamma camera. The effects of ZK 36374, a prostacyclin analogue, on deposition of platelets in the oxygenator and atrial line filter were also investigated. Total platelet deposition in the placebo group ranged from 2.2% to 31.7%, mean 13.9 +/- 7.8%; n = 15, and was significantly higher than the deposition in the treatment group, range 0.7% to 9.4%, mean 3.9 +/- 2.6%; n = 16, P less than 0.001. There was also a highly significant correlation between the gamma camera and whole body monitor measurements, r = 0.99, P less than 0.001, with no systematic difference between the techniques. This study demonstrates that accurate quantitative assessment of platelet deposition can be achieved with either the gamma camera or whole body monitor. In addition, significant reduction in platelet sequestration in the extracorporeal circuit can be achieved by using ZK 36374 during the bypass operation.

摘要

相似文献

1
Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue.
Eur J Nucl Med. 1989;15(3):128-32. doi: 10.1007/BF00254624.
2
Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.改善体外循环期间激活的血小板的有害作用。血栓素合成酶抑制剂与前列环素类似物的比较。
J Thorac Cardiovasc Surg. 1985 Feb;89(2):190-5.
3
Quantification of extracorporeal white cell and platelet deposition in cardiopulmonary bypass: comparison of membrane and bubble oxygenators.体外循环中白细胞和血小板在体外的沉积定量:膜式氧合器与鼓泡式氧合器的比较
Nucl Med Commun. 1996 May;17(5):378-84. doi: 10.1097/00006231-199605000-00005.
4
Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).伊洛前列素(ZK36374)预防心脏直视手术期间肝素诱导的血小板减少症。
Surgery. 1987 Nov;102(5):796-807.
5
Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.体外循环期间一氧化氮气体与伊洛前列素联合应用可减轻血小板功能障碍:一项初步临床研究。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):782-90. doi: 10.1016/j.jtcvs.2004.06.049.
6
Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
J Thorac Cardiovasc Surg. 1982 Jul;84(1):39-43.
7
[Use of a synthetic prostacyclin in extracorporeal circulation].[合成前列环素在体外循环中的应用]
Presse Med. 1992 Jan 25;21(3):113-8.
8
Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
Ann Thorac Surg. 1995 Jan;59(1):149-53. doi: 10.1016/0003-4975(94)00721-i.
9
A double blind study of prostacyclin in cardiopulmonary bypass surgery.前列环素在体外循环心脏手术中的双盲研究。
Br J Haematol. 1981 Nov;49(3):415-23. doi: 10.1111/j.1365-2141.1981.tb07244.x.
10
Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
Acta Haematol. 1985;73(4):224-7. doi: 10.1159/000206333.

引用本文的文献

1
Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.伊洛前列素。对其药效学和药代动力学特性以及在周围血管疾病、心肌缺血和体外循环手术中的治疗潜力的综述。
Drugs. 1992 Jun;43(6):889-924. doi: 10.2165/00003495-199243060-00008.

本文引用的文献

1
Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
J Thorac Cardiovasc Surg. 1982 Jul;84(1):39-43.
2
Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass.体外循环期间铟111标记的人血小板的动力学及滞留部位
J Thorac Cardiovasc Surg. 1981 Jun;81(6):880-6.
3
Prostacyclin in cardiopulmonary bypass operations.
J Thorac Cardiovasc Surg. 1982 Oct;84(4):601-8.
4
Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release.
体外循环患者异常出血的机制:与选择性α-颗粒释放相关的获得性短暂血小板功能障碍。
Blood. 1980 Nov;56(5):824-34.
5
The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.前列环素输注对体外循环患者血小板止血功能的影响。
J Thorac Cardiovasc Surg. 1984 Apr;87(4):550-5.
6
The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.一种新型卡前列素衍生物(ZK 36 374)的抗血小板和心血管作用——在体外与前列环素(PGI2)等效。
Naunyn Schmiedebergs Arch Pharmacol. 1981 Jun;316(3):252-5. doi: 10.1007/BF00505658.
7
Prostacyclin administration during cardiopulmonary bypass in man.人体体外循环期间前列环素的应用。
Lancet. 1981 Apr 11;1(8224):800-4. doi: 10.1016/s0140-6736(81)92680-5.
8
Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters.
J Thorac Cardiovasc Surg. 1974 Feb;67(2):258-65.
9
Effect of cardiac operation on platelets.
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 1):434-41.
10
Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.依洛前列素(ZK36374),一种前列环素的稳定类似物,在模拟体外循环过程中可保护血小板。
J Thorac Cardiovasc Surg. 1985 Jun;89(6):926-33.